4.5 Editorial Material

Importance of Quantifying Drug-Target Engagement in Cells

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 11, 期 4, 页码 403-406

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00570

关键词

-

资金

  1. Engineering and Physical Sciences Research Council (EPSRC)
  2. Medical Research Council (MRC) [EP/L016044/1, 1097737]
  3. AbbVie
  4. Bayer Pharma AG
  5. Boehringer Ingelheim
  6. Canada Foundation for Innovation
  7. Eshelman Institute for Innovation
  8. Genome Canada
  9. Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant] [115766]
  10. Janssen
  11. Merck KGaA Darmstadt Germany
  12. MSD
  13. Novartis Pharma AG
  14. Ontario Ministry of Economic Development and Innovation
  15. Pfizer
  16. Sao Paulo Research Foundation-FAPESP
  17. Takeda
  18. Wellcome [106169/ZZ14/Z]

向作者/读者索取更多资源

Measuring and quantifying the binding of a drug to a protein target inside living cells and thereby correlating biochemical or biophysical activity with target engagement in cells or tissue represents a key step in target validation and drug development. A prototypic target engagement assay should allow for unbiased determination of small molecule-protein interactions in order to confirm cellular mechanism-of-action (MoA) while avoiding major artificial perturbations of cellular homeostasis and integrity. Recently, several new additions to the chemical biology toolbox have expanded our ability to study drug action in intact cells and enabled surveying of intracellular residence time and binding kinetics, which are particularly important for potent receptor ligands and therapeutic moieties with limited therapeutic index.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据